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Mapping robust genetic variants associated with exercise responses 1 
Abstract 2 
This review summarised robust and consistent genetic variants associated with aerobic-3 
related and resistance-related phenotypes. In total we highlight 12 SNPs and 7 SNPs that 4 
are robustly associated with variance in aerobic-related and resistance-related phenotypes 5 
respectively. To date, there is very little literature ascribed to understanding the interplay 6 
between genes and environmental factors and the development of physiological traits. We 7 
discuss future directions, including large-scale exercise studies to elucidate the functional 8 
relevance of the discovered genomic markers. This approach will allow more rigour and 9 
reproducible research in the field of exercise genomics. 10 
 11 
Introduction 12 
Both aerobic and strength exercise training lower the incidence of many chronic diseases 13 
via a number of mechanisms, including increased skeletal muscle mitochondrial function 14 
[1], modulation of the sympathetic nervous and immune systems, and optimization of the 15 
neuroendocrine system [2]. These mechanisms act as buffers against chronic diseases, 16 
minimizing inflammatory state, and enhancing neuroplasticity and growth factor 17 
expression [3]. However, large inter-individual differences exist in the physiological 18 
responses to any given exercise training (also called “trainability”) [4, 5], and recently 19 
new statistical methods have been developed to properly isolate individual responses 20 
from random error [6]. Large trainability has been observed in many physical fitness 21 
parameters [7], including maximal oxygen uptake (VO2max) [8, 9], resting heart rate [9], 22 
exercise heart rate [9], aerobic threshold [10], anaerobic threshold [9], resting muscle 23 
glycogen content, muscle enzyme activity [11], as well as muscle mass and strength [12, 24 
13].   25 
 26 
The heritable component of trainability is large, with genetics explaining 47% of the 27 
variance in VO2 peak trainability, and around 52% in resistance variability [14]. The 28 
contribution of familial factors (genetics and environment) to trainability was 29 
demonstrated in the seminal HERITAGE family study [15]. This study indicated that 30 
VO2max was more variable between families than within families at baseline [16], and in 31 
response to exercise training [17], thus suggesting that DNA sequence variations could 32 
modulate exercise responses [4, 18]. Pinpointing the responsible gene variants could 33 
illuminate the fundamental mechanisms driving this heterogeneity in response to exercise 34 
training [18].  35 
 36 
The genetic contribution to trainability has been investigated by two different approaches: 37 
candidate genes and genome-wide association (GWAS) study. The GWAS approach 38 
involves scanning several hundred thousand (currently up to 5 million) DNA markers 39 
across the human genome to find genetic variations associated with a particular trait. One 40 
of the advantages of the GWAS approach is that it is unbiased and hypothesis-free. In 41 
contrast, candidate gene studies require knowledge of the trait of interest and is 42 
particularly useful to validate the functional impact of gene loci such as those identified 43 
by GWAS [19]. GWAS have demonstrated that trainability is polygenic (i.e., influenced 44 
by many genetic variants), and that people harbouring the same genotypes in specific 45 
gene variants respond more similarly to exercise training than people harbouring different 46 
genotypes [20-23]. These variants may modulate gene expression that is essential to the 47 
molecular adaptation to exercise training, since molecular processes mediate metabolism, 48 
angiogenesis, cardiac and skeletal myofibre hypertrophy, and other processes that lead to 49 
better fitness [24].  50 
 51 
While many SNPs have been associated with exercise response and trainability. The vast 52 
majority of the genes previously identified have not been replicated [25]. Replication in 53 
an independent cohort is important as it increases the likelihood that results are true and 54 
reduces the number of false positives [26, 27]. In this review we summarised SNPs 55 
associated with both resistance and aerobic trainability and have been replicated in two 56 
independent cohorts. In addition, we have screened these SNPs with the goal of 57 
identifying SNPs at trainability-associated loci that may have functional relevance. 58 
Further, we discussed future directions of performing large-scale exercise studies to 59 
elucidate the functional relevance of the discovered genomic markers. This approach will 60 
allow more rigour and reproducible research in the field of exercise genomics. 61 
 62 
Materials and methods 63 
To provide a robust and comprehensive narrative review, a semi-structured search was 64 
performed (July 2019) to identify all studies relating to genetic variants and exercise 65 
trainability. Three electronic databases (PUBMED, MEDLINE and SCOPUS) were used 66 
to identify relevant articles using the following keywords “genes”, “genome”, “exercise”, 67 
“physical activity”, “aerobic capacity”, “resistance”, “strength”, “power”. We excluded 68 
studies where the sole focus was on populations with a diagnosed medical condition such 69 
type 2 diabetes mellitus, any inflammatory conditions, and cardiovascular disease. 70 
Articles were separated in two categories: genetic variants associated with either aerobic 71 
or resistance trainability (Table 1 and 2). This review was conducted in accordance with 72 
the IJSM's ethical standards of the journal [28] 73 
 74 
Finally, we selected SNPs that were classified as robust and separated them according to 75 
whether they were related to the aerobic trainability or resistance trainability. We chose 76 
this criteria as it reflects the reliability of the findings and increases the likelihood that 77 
there is true association of the SNP with trainability [27]. It also allows us to identify and 78 
summarise SNPs with biological relevance which is useful for researchers to ‘select’ 79 
candidate SNPs to identify causality and purpose of gene [29]. 80 
SNPs were considered robust if: 81 
1) Consistent association with a given phenotype in at least two independent cohorts. 82 
2) SNPs were shown to have functional relevance in an animal model or cell culture, with 83 
gene expression/DNA methylation Quantitative Trait Loci (QTLs) analysis or network, 84 
and enrichment analysis.  85 
 86 
Aerobic Trainability 87 
Twin and family studies indicate that ~22–57% of aerobic fitness variability between 88 
individuals can be explained by genetics and therefore plays an important role in the range 89 
of aerobic phenotypes observed in a population [30]. Here, we briefly describe some of 90 
the robust SNPs that have been associated with aerobic trainability, which means they 91 
were replicated in at least 2 independent cohorts and were shown to have functional 92 
relevance.  93 
 94 
A bioinformatic analysis study conducted by Ghosh et al. found that the greatest number 95 
of SNPs were annotated to the PPAR signalling pathway suggesting its importance in 96 
VO2max trainability [31]. As such the most widely studied genes within this pathway are 97 
the peroxisome proliferator-activated receptors (PPARA, PPARG, and PPARD) and their 98 
transcriptional coactivators (PPARGC1A and PPARGC1B). These genes have been 99 
linked to multiple aerobic phenotypes, including muscle morphology, aerobic capacity 100 
and endurance performance [32, 33]. PPARD is expressed predominantly in adipocytes 101 
and skeletal muscle where it promotes fatty acid oxidation [34]. In the HERITAGE family 102 
study, the rs2016520 SNP (C allele) located in PPARD was associated with reduced 103 
VO2max and maximal power output after a 20 week endurance training intervention in 104 
African-Americans but not in Caucasians [35]. In vitro and animal studies show that the 105 
minor allele (C allele) in this SNP (rs2016520) results in higher PPARD transcriptional 106 
activity, which in turn promotes lipid accumulation and the alters normal regulation of 107 
lipid uptake and storage [34, 36, 37]. In a European cohort it was shown that the PPARD 108 
rs2267668 SNP was associated with VO2peak and anaerobic threshold after a 9-month 109 
lifestyle intervention [38]. They then confirmed that in human primary cell lines that those 110 
carrying the minor allele at rs2267668 (G allele) were associated with lower 111 
mitochondrial activity, demonstrating a potential functional effect [38]. Taken together, 112 
PPARD locus may play a role in aerobic trainability, but larger cohorts of different 113 
ancestries and, more in depth functional studies to determine causal SNP are needed to 114 
confirm this.  115 
 116 
The transcriptional co-activator PPARGC1A interacts with PPARD and regulates 117 
mitochondrial biogenesis, angiogenesis, lipolysis and adipogenesis [39]. Four candidate 118 
gene studies, predominantly in men, found consistent associations of rs8192678 within 119 
PPARGC1A and aerobic capacity in Europeans [38, 40-42]. While in the Han Chinese 120 
cohort another nearby SNP (rs6821591) was associated with VO2max specifically, the G 121 
allele was associated with increased VO2max compared to those carrying the A allele [43]. 122 
Work conducted in a Han Chinese cohort found that the PPARGC1A rs6821591 SNP had 123 
functional significance as gene expression was altered and this was dependent on 124 
genotype (A v G allele) with the G allele displaying increased PGC-1α gene expression 125 
[44]. Overexpression of PGC-1α in an animal model showed increased Type 1 fibres in 126 
muscles that are normally Type II fibre type dense and this induced increases in resistance 127 
to fatigue, inferring increased aerobic capacity [45]. These population-specific results 128 
indicate that it is the PPARGC1A locus itself, rather than individual SNPs located within 129 
that locus, may be important for trainability [43, 46].  130 
 131 
Currently 26 SNPs associated with VO2max trainability were identified in a GWAS and 132 
were validated in 2 separate cohorts (detailed in Table 2) [23]. They accounted for 49% 133 
of VO2max trainability and were able to classify responders and non-responders [23, 47]. 134 
Whether these SNPs are directly involved in gene function or regulation of genes is the 135 
next step to validate these findings. The most robust is the SNP rs6552828 located near 136 
the ACSL1 gene which was the strongest predictor (~6%) of aerobic trainability (VO2max) 137 
[23]. It has subsequently been validated in a bioinformatics pathway analysis and found 138 
to be strongly correlated to the aerobic electron transport chain phenotype and the PPAR 139 
signalling pathway providing a robust candidate gene in VO2max trainability [31]. ACSL1 140 
regulates lipid metabolism by facilitating the transport of long chain fatty acids into the 141 
mitochondria and is an essential step in fatty acid oxidation [48]. Timmons et al. 142 
integrated RNA profiles with genetic variants and found the following genes CD44, and 143 
DAAM1, also discovered in the Bouchard et al. GWAS, were associated with gene 144 
expression changes [49]. Gene expression of CD44 was up-regulated in response to 145 
endurance training [49] and was strongly associated with phenotypic terms associated 146 
with aerobic exercise such as; cardiovascular physiological processes, muscle 147 
contraction, physical fitness and aerobic electron transport chain [31] indicating that this 148 
gene and any alterations to its function (i.e. via SNPs) may play in important role in 149 
aerobic trainability. While these genes certainly provide robust genes, there are still 150 
limitations in determining the causality of these particular SNPs in the molecular 151 
mechanisms affecting aerobic trainability. 152 
 153 
Many candidate gene and GWAS studies have been conducted and this review highlights 154 
the large collection of candidate genes that have been associated with aerobic trainability.  155 
Only 12 SNPs have been robustly associated with aerobic trainability (Table 3) meaning 156 
that have been validated in at least 2 independent cohorts and were shown to have some 157 
functional relevance. Subsequent studies should focus on understanding the functional 158 
role of the SNPs that have been replicated as this review highlights the lack of 159 
understanding of the molecular mechanism and limits our understanding of aerobic 160 
trainability.  161 
 162 
Resistance Trainability  163 
Muscular strength and power show a heritability estimated around 52% [14]. Skeletal 164 
muscle strength is defined as the force produced by muscle contraction. A variety of 165 
measures have been investigated, including muscle strength, maximal voluntary 166 
contraction (MVC), 1 repetition maximum (1RM) and handgrip strength. While the 167 
production of skeletal muscle power is defined as how much force can be produced and 168 
the velocity at which it is produced. The production of power can be measured at the by 169 
undertaking tests such as Wingate’s, counter movement jumps (CMJ) and vertical jumps 170 
(VJ).  171 
 172 
The ACE I/D and ACTN3 R/X SNPs are two of the most extensively studied gene loci. 173 
We have chosen not to discuss ACTN3 here as it has recently been reviewed in detail by 174 
Del Coso et al. [50] and instead focus on the ACE I/D SNP. The ACE gene encodes the 175 
angiotensin-converting enzyme that is a central component of the renin-angiotensin-176 
system [51]. The ACE I/D results in either  an insertion (I) or deletion (D) of a 287-177 
basepair region in intron 16 of the gene [52] and can alter the levels of ACE in the blood 178 
[52]. It has recently been shown that the polymorphism can manipulate the activity of the 179 
C- and N-terminal domain in the enzyme [53]. Further, exercise can decrease the enzyme 180 
activity in the C-terminal domain and increase the activity in the N- terminal domain 181 
which results in improved blood flow and proliferation of red blood cells [53]. It is 182 
thought that the I allele confers enhanced endurance performance while the D allele is 183 
thought to confer increased muscle power and strength [54]. The D allele was consistently 184 
shown across 6 separate candidate gene studies to be associated with greater gains in 185 
strength after resistance training and this was consistent across sex and age [55-60]. While 186 
the literature is consistent regarding muscular strength, the association with muscular 187 
power is less convincing [55, 61-63]. The D allele in ACE was associated with CMJ in 188 
older females after a 12-week power training program [58] and in young males after a 189 
high intensity training program [13]. However, it was the I allele in ACE that was 190 
associated with a higher baseline VJ at baseline in males and females [62]. Another two 191 
studies did not find any association between the ACE I/D and skeletal muscle power at 192 
baseline or in response to resistance training [61, 63]. ACE provides a robust candidate 193 
gene for explaining variation in muscular strength but not muscular power suggesting that 194 
this gene loci may only explain some of the inter-individual resistance variability 195 
dependent on type of resistance exercise.  196 
 197 
Many of the candidate genes in resistance trainability came from a large multi-centre trial 198 
(FAMuSS) which aimed to identify nonsynonymous SNPs with functional effects on 199 
muscle power and strength [64]. These include: Glucocorticoid receptor (NR3C1) [65], 200 
alpha-actinin 3 (ACTN3) [66], Chemokine (C-C motif) ligand 2 (CCL2) [67], Chemokine 201 
(C-C motif) ligand 2 Receptor (CCR2) [67], ACE [60], Solute carrier family 30 (zinc 202 
transporter), member eight gene (SLC30A8) [68], Leptin (LEP) and Leptin receptor 203 
(LEPR) [69]. The FAMuSS study was conducted in young (18-40 years old) males 204 
(N=247) and females (N=355) of predominantly European-American ancestry. 205 
Participants underwent a 12-week unilateral resistance program consisting of upper arm 206 
exercises in the non-dominant arm [60]. Only IL-15RA, ACTN3 and ACE  from this series 207 
of studies were replicated in separate cohorts and have functional relevance. In the IL-208 
15RA locus the rs2296135 SNP was associated gains in muscular strength and replicated 209 
in two different studies in cohort of European ancestry [70, 71]. When the gene IL-15RA 210 
is knocked down in an animal model it altered the contractile properties and fatigability 211 
in skeletal muscle fibres [72]. While the locus is important it not yet clear which SNPs is 212 
responsible for altering the function of IL-15RA protein. Although SNPs within CCL2, 213 
CCR2 and CNTF have not been replicated they interestingly showed sex-specific 214 
associations with muscle strength. CTNF polymorphisms were associated with strength 215 
gains only in females [73], which was subsequently confirmed in a South Korean cohort 216 
[74]. SNPs in CCL2 and CCR2 were associated strength gains in males only [67]. This 217 
indicates potential sex-specific differences in the genetic architecture of complex traits 218 
and should be incorporated into study design [75, 76]. In addition PTK2, CNTF, IL-6, 219 
PPARA and VDR candidate genes have been replicated with functional relevance [13, 220 
73].  221 
 222 
In total 7 SNPs (Table 3) were robustly associated with resistance variability. While there 223 
are plethora of candidate gene studies no GWAS have been conducted that specifically 224 
focuses on resistance trainability.  225 
 226 
Functional Validation   227 
We have identified 12 SNPs and 7 SNPs that are robustly associated with variance in 228 
aerobic and resistance trainability respectively. The next steps are to a) identify the causal 229 
SNP, b) annotate the casual SNP to the correct gene and then c) to establish the functional 230 
relevance of the gene [47]. The overall evidence from literature connecting causal genes 231 
to trainability is relatively low [31]. If we hope to identify the casual variants or genes it 232 
is vital that we begin to integrate ‘omic’ technologies from the genome and epigenome to 233 
transcriptome to proteome and metabolome which can capture a complete picture of 234 
complex human traits such as aerobic and resistance trainability [77, 78].  235 
 236 
There have been attempts to associate molecular pathways or ‘molecular phenotypes’ 237 
with physiological phenotypes of aerobic and resistance trainability [79-81]. Sarzynski et 238 
al. applied this systems biology approach by combining the 21 SNP identified in a GWAS 239 
from the HERITAGE study cohort (Table 2) [15, 23] and examined the joint contributions 240 
of these SNPs to exercise response [47]. This approach identified potential pathways in 241 
calcium signalling, energy sensing and partitioning, mitochondrial biogenesis, 242 
angiogenesis, immune functions, and regulation of autophagy and apoptosis, providing 243 
important pathways that can be investigated more closely [47]. Another integrative 244 
approach is expression quantitative trait loci (eQTLs) analysis that leverages gene loci 245 
identified from GWAS and integrate these with gene expression data to identify 246 
differential gene expression levels to try and uncover the ‘molecular phenotype’ that lead 247 
to these variations in exercise response [82, 83]. Willems et al. identified the rs6565586 248 
SNP in ACTG1 as a strong candidate gene in inter-individual variability in the resistance-249 
related phenotype (hand grip strength) and correlated this with a lower expression of 250 
mRNA in skeletal muscle. ACTG1 encodes Actin Gamma 1 and is involved in the 251 
structure and function of skeletal muscle fibres. Interestingly, in a knock out mouse 252 
model, animals displayed overt muscle weakness [84]. This type of analysis presented an 253 
ideal candidate gene to begin understanding the molecular mechanisms in human skeletal 254 
muscle.  255 
 256 
To establish causality of genetic variants in aerobic and resistance trainability the field 257 
needs to move forward beyond association analysis. The type of follow-up experiment 258 
will depend on the location of SNP within the gene. For SNPs within coding regions 259 
ideally experiments are performed to study the effect of the SNP has on protein structure 260 
and function. For SNPs within in non-coding regions it more difficult to determine as 261 
they may not directly affect a gene but alter/regulate transcription factors and mediate 262 
alterations in genes this way [77]. However, with the introduction of the large epigenetic 263 
database ENCODE (Encyclopaedia of DNA elements) we can now identify the 264 
transcription factor association, chromatin structure and histone modification of target 265 
genes [85] and more recently enhancers providing candidate gene targets for follow up 266 
analysis [86]. With the discovery of CRISPR Cas-9 genome-editing tool in 2012 [87] this 267 
has paved the way for establishing causality of SNPs and the functional effects of them. 268 
This has been used to great effect for establishing causal genes implicated in insulin 269 
resistance whereby they were able to determine the casual effect of 12 candidate genes 270 
that had previously been identified in a GWAS [88]. To date no experiments have been 271 
conducted using this gene-editing tool to establish the function and causality of candidate 272 
genes of trainability beyond association analysis.  273 
 274 
There is still much work to do before personalised exercise prescription (both in a clinical 275 
and elite athlete setting) can be based on an individual’s genetics. However, there are 276 
concerted efforts taking place to make this possible such as the Athlome Project 277 
Consortium and the Gene SMART (Skeletal Muscle Response to Training), recently 278 
launched with the aim of uncovering the genetic variation underlying athletic 279 
performance, adaptation to exercise training, and exercise-related musculoskeletal 280 
injuries [89, 90]. These, and other initiatives will allow for population-based approach to 281 
understand the role of genes and environmental factors contributing to the complex 282 
exercise response phenotype [91]. 283 
 284 
This review summarised robust genetic variants that have been associated with aerobic 285 
and resistance trainability. To date, there is very little literature ascribed to understanding 286 
the interplay between genes and environmental factors and the development of 287 
physiological traits. Therefore, much work remains to identify causal variants and 288 
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 621 
Table legends 622 
 623 
Table 1. Gene variants associated with aerobic trainability.  624 
 AT, Anaerobic Threshold; CO, Cardiac Output; VT, Ventilatory Threshold; RE, 625 
Running Economy; LVM, left ventricular mass; N/A, information not available; RP, 626 
Running Performance; SV, Stroke Volume. 627 
 628 
Table 2. Gene variants associated with resistance trainability.  629 
1RM, one maximal repetition; CMJ, counter movement jump; CSA, cross sectional area; 630 
LVM, Left ventricle mass; MVC, maximal voluntary contraction; N/A, information not 631 
available; RT, resistance training; STS, sit to stand test. 632 
 633 
Table 3. Robust SNPs associated with aerobic or resistance trainability.  634 
TBC, Allele to be confirmed; *Linkage Disequilibrium above 80% according to ensemble 635 
LD calculator. 636 
 637 
Table 1. Gene variants associated with aerobic trainability.  1 
Author, Date Sample Size Sex (% Males) Age 
Ancestry/Country 
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Table 2: Gene variants associated with resistance trainability. 1 




Age Ancestry/County of 
origin/ethnicity 
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Males only Age 18-
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MTSN KR (+) Hypertrophy in Biceps and 
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MTSN AT + TT (+) Hypertrophy in Biceps 
Arm and Leg 
resistance 
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Females only Age 65.5 
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1RM, power (CMJ), functional capacity (STS) 
 
ACTN3 RR (+) maximal dynamic strength 
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Post Intervention: ACE II/ID (+) Maximal 
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Table 3. Robust SNPs associated with aerobic or resistance trainability.  
Aerobic trainability Resistance trainability 
SNP Nearest Gene 
Beneficial 
allele 
SNP Nearest Gene 
Beneficial 
allele 
rs6552828 ACSL1 G rs4646994* ACE D 
rs699 AGT T rs1799752* ACE D 
rs6090314 BIRC A rs4340* ACE D 
rs12580476 C12orf36 TBC rs13447447* ACE D 
rs884736 CAMTA1 G rs1815739 ACTN3 R 
rs353625 CD44 TBC rs2296135 IL15 RA C 
rs1956197 DAAM1 G rs4253778 PPARA C 
rs17117533 NDN A    
rs8192678 PPARGC1A G    
rs10921078 RGS18 A    
rs7531957 RYR2 TBC    
rs11715829 ZIC4 G    
 
 
 
